Smart Hospitals: Global Markets
Report Highlights
The global smart hospitals market should reach $111.99 billion by 2026 from $39.16 billion in 2021 at a compound annual growth rate (CAGR) of 23.4% for the forecast period of 2021 to 2026.
Report Includes
- 29 tables
- An overview of the global smart hospitals market
- Estimation of the market size and analyses of the global market trends, with data from 2019 to 2020, estimates for 2021, with projection of CAGR through 2026
- Analysis of new opportunities, challenges, and technological changes within the industry and highlights of the market potential by component, connectivity, application and region
- Coverage of key technologies of digital health market and classification of smart healthcare
- Detailed analysis of the current market trends and forecast, new products launches and product enhancement, technological innovation, upcoming technologies and the technical progress of the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships and other key market strategies
- Company profiles of major players in the market, including Allscripts Healthcare LLC, General Electric Co., IBM, Medtronic PLC and Siemens
Report Scope
The scope of this study entails the worldwide market for smart hospitals. The report covers the entire market for smart hospitals, which incorporates three main components: hardware, system and software and service. Based on application, smart hospitals are divided into remote medicine management, medical connected imaging, electronic health records and clinical workflows, and others. By connectivity, the market is segmented between wired and wireless.
By geography, the market has been divided into four regions: North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered. For market estimates, data have been provided for the year 2020 as the base year, with forecasts for 2021-2026. Estimated values are based on drug manufacturer total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.